Introducing the New Retatrutide ELISA Kit

We are excited to introduce the Retatrutide ELISA Kit (S-1566), developed for precise and reliable quantification of Retatrutide in biological samples.

As Retatrutide advances through Phase III clinical development as a triple receptor agonist targeting GIPR, GLP-1R, and GCGR, accurate bioanalysis is essential for PK/PD studies, immunogenicity assessment, and clinical research applications.

Key Features:

  • High specificity for Retatrutide detection
  • Broad assay range: 0-5,000 ng/mL
  • Wide linear range: 16-388 ng/mL
  • Suitable for serum and plasma samples
  • Supports PK/PD bioanalysis and immunogenicity studies
  • Easy-to-use ELISA format for high-throughput sample testing

Ideal Applications:

  • Clinical PK/PD and toxicology evaluation
  • Phase I human PK and tolerability studies
  • Phase II/III efficacy and safety analysis
  • Drug-drug interaction studies
  • Immunogenicity assessment

Accelerate your metabolic disease and peptide therapeutic research with the Retatrutide ELISA Kit (S-1566).

For technical inquiries, bulk orders, or custom applications, contact us at info@bma.ch

We help you keep your research moving forward!

Your BMA team

Diabetes and Obesity Research discover all articles